Aneurysm Clinical Trial 20203053

[LCID Study Number: 20203053]

Statins Use in Intracerebral Hemorrhage Patients (SATURN)

The purpose of this study is to determine whether continuation vs. discontinuation of statin drugs after spontaneous lobar intracerebral hemorrhage (ICH) is the best strategy; and whether the decision to continue/discontinue statins should be influenced by an individual’s Apolipoprotein-E (APOE) genotype.

Disease/Condition: Aneurysm

Department: Neurology

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-2400

View NCT ID 03936361 on ClinicalTrials.gov
Protocol #: 20203053
Principal Investigator(s): Siddharth Sehgal
Study Coordinator(s): Tanya Fennell
Trial Phase: Sponsor Initiated Study Phase 3